Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-25-020675

CEO and CFO bought 2,300 shares at $9.26 ($21,298)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Snehal CEO and CFO 2025-10-31 Purchase +2,300 $9.26 $21,298 5,572,902 D
Open-market purchases · 2,300 sh · avg $9.26 · $21,298
Loading xslF345X05/ownership.xml…